Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

10X Capital Management, Llc

10% Owner at Galectin Therapeutics Inc (GALT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.2M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 8SEC GALTGalectin Therapeutics Inc Sell 30,0005,802,207 held (−1%) $5.47 $164K -28.0%
Dec 8SEC GALTGalectin Therapeutics Inc Sell 132,0695,670,138 held (−2%) $5.73 $757K -31.2%
Dec 4SEC GALTGalectin Therapeutics Inc Sell 30,0005,802,207 held (−1%) $5.47 $164K -28.0%
Dec 4SEC GALTGalectin Therapeutics Inc Sell 120,0005,682,207 held (−2%) $5.73 $688K -31.2%
Nov 12SEC GALTGalectin Therapeutics Inc Sell 40,0005,832,207 held (−1%) $5.25 $210K -25.0%
Oct 24SEC GALTGalectin Therapeutics Inc Sell 20,0005,902,207 held (−0%) $4.93 $99K -20.1%
Oct 24SEC GALTGalectin Therapeutics Inc Sell 30,0005,872,207 held (−1%) $4.94 $148K -20.2%